Suboptimal use of intravenous contrast during radiotherapy planning in the UK.

2.50
Hdl Handle:
http://hdl.handle.net/10541/58713
Title:
Suboptimal use of intravenous contrast during radiotherapy planning in the UK.
Authors:
Kim, Su Woon; Russell, Wanda; Price, Patricia M; Saleem, Azeem
Abstract:
We aimed to evaluate the use of intravenous (IV) contrast during acquisition of radiotherapy planning (RTP) scans and to compare current usage with the Royal College of Radiologists' (RCR) recommendations. Questionnaires were circulated via the Academic Clinical Oncology and Radiobiology Research Network (ACORRN) website, email and post to 60 UK radiotherapy centre managers. Questions were asked regarding the (i) tumour sites where IV contrast was used, (ii) person administering the contrast, (iii) availability of dynamic pump, (iv) tumour sites that centres wished to use contrast, (v) reasons for not using contrast and (vi) awareness of RCR recommendations. 50 (83%) centres responded to the questionnaire, of which 27 responded via the ACCORN website and 18 by e-mail. Despite 38 out of 50 responding centres using IV contrast, and accessibility to dynamic pumps existing in 39 centres, IV contrast usage was suboptimal, with more than half of the centres (27/50; 54%) wishing to use it at more tumour sites. IV contrast was most often used during RTP of the brain, with suboptimal usage in lung tumours. None of the 50 centres administered IV contrast during RTP scan acquisition in all of the 8 RCR recommended tumour sites. Radiographers were mainly responsible for contrast administration, and a lack of staff was cited as the main reason for suboptimal contrast usage. Disappointingly, only 35 of the 50 radiotherapy managers (70%) were aware of the RCR recommendations. Redress of the underlying reasons for suboptimal IV contrast administration during RTP, including acquisition of the necessary skill mix by staff and implementation of RCR recommendations, would help standardize UK practice.
Affiliation:
Department of Clinical Oncology, Christie Hospital, Manchester, UK.
Citation:
Suboptimal use of intravenous contrast during radiotherapy planning in the UK. 2008, 81 (972):963-9 Br J Radiol
Journal:
The British Journal of Radiology
Issue Date:
Dec-2008
URI:
http://hdl.handle.net/10541/58713
DOI:
10.1259/bjr/24432468
PubMed ID:
18762482
Type:
Article
Language:
en
ISSN:
1748-880X
Appears in Collections:
All Christie Publications ; Clinical Oncology; Academic Department of Radiation Oncology - ADRO

Full metadata record

DC FieldValue Language
dc.contributor.authorKim, Su Woon-
dc.contributor.authorRussell, Wanda-
dc.contributor.authorPrice, Patricia M-
dc.contributor.authorSaleem, Azeem-
dc.date.accessioned2009-04-01T23:17:29Z-
dc.date.available2009-04-01T23:17:29Z-
dc.date.issued2008-12-
dc.identifier.citationSuboptimal use of intravenous contrast during radiotherapy planning in the UK. 2008, 81 (972):963-9 Br J Radiolen
dc.identifier.issn1748-880X-
dc.identifier.pmid18762482-
dc.identifier.doi10.1259/bjr/24432468-
dc.identifier.urihttp://hdl.handle.net/10541/58713-
dc.description.abstractWe aimed to evaluate the use of intravenous (IV) contrast during acquisition of radiotherapy planning (RTP) scans and to compare current usage with the Royal College of Radiologists' (RCR) recommendations. Questionnaires were circulated via the Academic Clinical Oncology and Radiobiology Research Network (ACORRN) website, email and post to 60 UK radiotherapy centre managers. Questions were asked regarding the (i) tumour sites where IV contrast was used, (ii) person administering the contrast, (iii) availability of dynamic pump, (iv) tumour sites that centres wished to use contrast, (v) reasons for not using contrast and (vi) awareness of RCR recommendations. 50 (83%) centres responded to the questionnaire, of which 27 responded via the ACCORN website and 18 by e-mail. Despite 38 out of 50 responding centres using IV contrast, and accessibility to dynamic pumps existing in 39 centres, IV contrast usage was suboptimal, with more than half of the centres (27/50; 54%) wishing to use it at more tumour sites. IV contrast was most often used during RTP of the brain, with suboptimal usage in lung tumours. None of the 50 centres administered IV contrast during RTP scan acquisition in all of the 8 RCR recommended tumour sites. Radiographers were mainly responsible for contrast administration, and a lack of staff was cited as the main reason for suboptimal contrast usage. Disappointingly, only 35 of the 50 radiotherapy managers (70%) were aware of the RCR recommendations. Redress of the underlying reasons for suboptimal IV contrast administration during RTP, including acquisition of the necessary skill mix by staff and implementation of RCR recommendations, would help standardize UK practice.en
dc.language.isoenen
dc.subjectCancer Radiotherapyen
dc.subjectIntravenous Contrasten
dc.subjectCanceren
dc.subject.meshAttitude of Health Personnel-
dc.subject.meshContrast Media-
dc.subject.meshDrug Utilization-
dc.subject.meshFemale-
dc.subject.meshGreat Britain-
dc.subject.meshHealth Care Surveys-
dc.subject.meshHumans-
dc.subject.meshInfusion Pumps-
dc.subject.meshInfusions, Intravenous-
dc.subject.meshMale-
dc.subject.meshNeoplasms-
dc.subject.meshRadiotherapy Planning, Computer-Assisted-
dc.subject.meshRadiotherapy, Conformal-
dc.titleSuboptimal use of intravenous contrast during radiotherapy planning in the UK.en
dc.typeArticleen
dc.contributor.departmentDepartment of Clinical Oncology, Christie Hospital, Manchester, UK.en
dc.identifier.journalThe British Journal of Radiologyen

Related articles on PubMed

All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.